Pyrimidine metabolism regulator-mediated molecular subtypes display tumor microenvironmental hallmarks and assist precision treatment in bladder cancer

BACKGROUND: Bladder cancer (BLCA) is a common urinary system malignancy with a significant morbidity and death rate worldwide. Non-muscle invasive BLCA accounts for over 75% of all BLCA cases. The imbalance of tumor metabolic pathways is associated with tumor formation and proliferation. Pyrimidine...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Zixuan, Li, Xiaohuan, Gu, Zhenchang, Xia, Xinhua, Yang, Jing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10470057/
https://www.ncbi.nlm.nih.gov/pubmed/37664033
http://dx.doi.org/10.3389/fonc.2023.1102518

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10470057/
https://www.ncbi.nlm.nih.gov/pubmed/37664033
http://dx.doi.org/10.3389/fonc.2023.1102518

Ejemplares similares